JenniferAlston(Alston)DeSimoneMD

Clinical Fellow in Dermatology, Brigham and Women's Hospital

Dr. DeSimone is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
8081 Innovation Park Dr
Level 5 - Chesapeake Clinic
Fairfax, VA 22031
Phone+1 571-472-1190

Fax+1 571-472-1188

Brigham and Womens HospitalFellowship, Cutaneous Oncology, 2011 - 2012
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2006 - 2010
MedStar Health Georgetown UniversityResidency, Internal Medicine/Dermatology, 2006 - 2010
Virginia Commonwealth University School of MedicineClass of 2005

PubMed

ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.
Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain
Transplantation and Cellular Therapy. 2024-11-01
1 citations
Merkel cell carcinoma.
Sach Thakker, Suraj Venna, Micah Belzberg, Sekwon Jang, Jennifer DeSimone
Journal of the American Academy of Dermatology. 2024-09-01
Managing large cutaneous squamous cell carcinoma with programmed cell death protein 1 inhibitor monotherapy: Real-world experience at a single center.
Sach Thakker, Mairead R Baker, Jafar Al-Mondhiry, Sekwon Jang, Jennifer A DeSimone
JAAD International. 2024-09-01

Other

Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma
DeSimone JA, Schmults CD, Karia PS
http://www.uptodate.com/contents/recognition-and-management-of-high-risk-aggressive-cutaneous-squamo
UpToDate, Wolters Kluwer Health - 2013-02-25

Expert Panel Develops Guidance to Manage Skin Cancer in Organ Transplant PatientsOctober 11th, 2021